<DOC>
	<DOC>NCT02380534</DOC>
	<brief_summary>To evaluate the effects of H.E.L.P. apheresis on lipid profile, Lp(a) level, and some inflammatory adypocytokines in patients with high cardiovascular risk.</brief_summary>
	<brief_title>Use of Apheretic Technologies in Cardiovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>high Lp(a) not responsive to diet and pharmacological treatment heart failure hepatic failure renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>High level of Lp(a)</keyword>
</DOC>